Hims & Hers’ earnings soar while GLP-1 drug crisis deepens—what this means for investors

Hims & Hers Health Inc. saw its stock surge following a robust quarterly earnings report, which showcased significant growth in revenue and subscriber numbers. Despite ... Read More